MedTrace Logo

Identification of Biomarkers for Patients with Vascular Anomalies

NCT03001180 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-11-06

No results posted yet for this study

Summary

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.

Conditions

  • Vascular Anomaly
  • Generalized Lymphatic Anomaly
  • Kaposiform Hemangioendothelioma
  • Kaposiform Lymphangiomatosis
  • Gorham-Stout Disease
  • Klippel Trenaunay Syndrome
  • Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi

Sponsors & Collaborators

  • Lymphangiomatosis and Gorham's Disease Alliance (LGDA)

    collaborator UNKNOWN

  • Klippel Trenaunay (KT) Support Group

    collaborator UNKNOWN

  • CLOVES Syndrome Community Support Group

    collaborator UNKNOWN

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Timothy LeCras, PhD · Children's Hospital Medical Center, Cincinnati

Eligibility

Min Age
1 Day
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2050-12-31
Completion
2050-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03001180 on ClinicalTrials.gov